Capital Investment Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.9K | Sell |
111
-242
| -69% | -$39K | ﹤0.01% | 887 |
|
|
2025
Q1 | $60.1K | Sell |
353
-21
| -6% | -$3.57K | 0.01% | 684 |
|
|
2024
Q4 | $62.2K | Buy |
374
+2
| +0.5% | +$333 | 0.01% | 629 |
|
|
2024
Q3 | $63.9K | Hold |
372
| – | – | 0.01% | 647 |
|
|
2024
Q2 | $57.2K | Hold |
372
| – | – | 0.01% | 643 |
|
|
2024
Q1 | $57.2K | Sell |
372
-286
| -43% | -$43.9K | 0.01% | 636 |
|
|
2023
Q4 | $104K | Sell |
658
-282
| -30% | -$44.6K | 0.01% | 557 |
|
|
2023
Q3 | $138K | Hold |
940
| – | – | 0.01% | 502 |
|
|
2023
Q2 | $144K | Buy |
940
+35
| +4% | +$5.36K | 0.01% | 499 |
|
|
2023
Q1 | $140K | Hold |
905
| – | – | 0.02% | 500 |
|
|
2022
Q4 | $139K | Buy |
905
+566
| +167% | +$87.2K | 0.02% | 504 |
|
|
2022
Q3 | $45K | Hold |
339
| – | – | 0.01% | 581 |
|
|
2022
Q2 | $46K | Hold |
339
| – | – | 0.01% | 599 |
|
|
2022
Q1 | $51K | Buy |
+339
| New | +$51K | 0.01% | 623 |
|
|
2021
Q3 | – | Sell |
-349
| Closed | -$60K | – | 773 |
|
|
2021
Q2 | $60K | Buy |
+349
| New | +$60K | 0.01% | 572 |
|
|
2021
Q1 | – | Sell |
-445
| Closed | -$75K | – | 740 |
|
|
2020
Q4 | $75K | Buy |
445
+285
| +178% | +$48K | 0.01% | 483 |
|
|
2020
Q3 | $25K | Buy |
160
+150
| +1,500% | +$23.4K | ﹤0.01% | 491 |
|
|
2020
Q2 | $2K | Hold |
10
| – | – | ﹤0.01% | 542 |
|
|
2020
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 547 |
|
|
2019
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 537 |
|
|
2019
Q3 | $1K | Buy |
10
+3
| +43% | +$300 | ﹤0.01% | 1317 |
|
|
2019
Q2 | $1K | Buy |
7
+5
| +250% | +$714 | ﹤0.01% | 1332 |
|
|
2019
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1223 |
|